Senate Eyes Limited Population Pathway For Antibiotics As Part Of Healthier Americans Effort

Senate health committee working groups are looking at legislation that would create a pathway for FDA to approve an antibacterial drug for a limited population, said a legislative assistant Tuesday (July 28). The measure, included in the 21st Century Cures Act passed by the House earlier this month, was introduced in the upper chamber by Sens. Orrin Hatch (R-UT) and Michael Bennet (D-CO) and is being looked at as part of the health committee’s Innovation for Healthier Americans Initiative. Matthew...